Ocular Manifestations in Patients with Human Immunodeficiency Virus Infection in the Pre-HAART Versus the HAART Era in the North Indian Population

REFERENCES

• Annual Report 2013–2014. Department of AIDS Control, Ministry of Health & Family Welfare, Government of India. 2014. Available at: http://www.naco.gov.in/upload/2014%20mslns/NACO_English%202013-14.pdf. Accessed September 7, 2015.
   Google Scholar
• Moraes HV, Jr. Ocular manifestations of HIV/AIDS. Curr Opin Ophthalmol. 2002;13:397–403.
   PubMedGoogle Scholar
• Jacobson MA, Stanley H, Holtzer C, et al. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30:231–233.
   PubMed Web of Science ®Google Scholar
• Kahraman G, Krepler K, Franz C, et al. Seven years of HAART impact on ophthalmic management of HIV-infected patients. Ocul Immunol Inflamm. 2005;13:213–218.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Holbrook JT, et al. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007;114:780–786.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Holbrook JT, et al. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 2007;114:787–793.
   PubMed Web of Science ®Google Scholar
• Jabs DA. AIDS and ophthalmology in 2004. Arch Ophthalmol. 2004;122:1040–1042.
   PubMedGoogle Scholar
• Chiou SH, Liu CY, Hsu WM, et al. Ophthalmic findings in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect. 2000;33:45–48.
   PubMedGoogle Scholar
• Miyamoto C, Yashiro S, Nagata Y, et al. [Ocular complications in patients infected with human immunodeficiency virus seen at the Acquired Immunodeficiency Syndrome Clinical Center]. Nippon Ganka Gakkai Zasshi. 2001;105:483–487.
   PubMedGoogle Scholar
• Ausayakhun S, Watananikorn S, Ittipunkul N, et al. Epidemiology of the ocular complications of HIV infection in Chiang Mai. J Med Assoc Thai. 2003;86:399–406.
   PubMedGoogle Scholar
• Wang J, You Q, Yang H, et al. Retinal findings in Chinese patients with HIV infection. Ophthalmic Res. 2008;40:98–100.
   PubMed Web of Science ®Google Scholar
• Lin YC, Yang CH, Lin CP, et al. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese. Ocul Immunol Inflamm. 2008;16:83–87.
   PubMed Web of Science ®Google Scholar
• Lai TY, Wong RL, Luk FO, et al. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Clin Experiment Ophthalmol. 2011;39:99–104.
   PubMed Web of Science ®Google Scholar
• Kaur A, Babu PG, Jacob M, et al. Clinical and laboratory profile of AIDS in India. J Acquir Immune Defic Syndr. 1992;5:883–889.
   PubMed Web of Science ®Google Scholar
• Lewallen S, Courtright P. HIV and AIDS and the eye in developing countries: a review. Arch Ophthalmol. 1997;115:1291–1295.
   PubMedGoogle Scholar
• Biswas J, Madhavan HN, George AE, et al. Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am J Ophthalmol. 2000;129:9–15.
   PubMed Web of Science ®Google Scholar
• WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of hiv-related disease in adults and children 2007. Available at: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf. Accessed September 7, 2015.
   Google Scholar
• Appendix A: AIDS-Defining Conditions. 2008. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a2.htm. Accessed September 7, 2015.
   Google Scholar
• Kumarasamy N, Patel A, Pujari S. Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to? Indian J Med Res. 2011;134:787–800.
   PubMed Web of Science ®Google Scholar
• Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995;93:623–683.
   PubMedGoogle Scholar
• Ford N, Shubber Z, Saranchuk P, et al. Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis. 2013;57:1351–1361.
   PubMed Web of Science ®Google Scholar
• Luo J, Jing D, Kozak I, et al. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China. Ophthalmic Epidemiol. 2013;20:170–175.
   PubMed Web of Science ®Google Scholar
• Shah SU, Kerkar SP, Pazare AR. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Br J Ophthalmol. 2009;93:88–90.
   PubMed Web of Science ®Google Scholar
• Pathai S, Deshpande A, Gilbert C, et al. Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study. BMC Infect Dis. 2009;9:158.
   PubMed Web of Science ®Google Scholar
• Sudharshan S, Kaleemunnisha S, Banu AA, et al. Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long-term study. J Ophthalmic Inflamm Infect. 2013;3:2.
   PubMedGoogle Scholar
• Sahu D, Namperumalsamy P, Walimbe P, et al. Ocular manifestations of HIV infection/AIDS in South Indian patients. Indian J Ophthalmol. 1999;47:79–85.
   Google Scholar
• Gharai S, Venkatesh P, Garg S, et al. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15:264–271.
   PubMed Web of Science ®Google Scholar
• Acharya PK, Venugopal KC, Karimsab DP, et al. Ocular manifestations in patients with HIV Infection/AIDS who were referred from the ART centre, Hassan, Karnataka, India. J Clin Diagn Res. 2012; 6:1756–1760.
   Google Scholar
• Ganekal S, Jhanji V, Dorairaj S, et al. Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South India. Ocul Immunol Inflamm. 2012;20:336–341.
   PubMed Web of Science ®Google Scholar
• Furrer H, Barloggio A, Egger M, et al. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma. Ophthalmology. 2003;110:432–436.
   PubMed Web of Science ®Google Scholar
• Kozak I, Sasik R, Freeman WR, et al. A degenerative retinal process in HIV-associated non-infectious retinopathy. PLOS ONE. 2013;8:e74712.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Drye L, Van Natta ML, et al. Incidence and long-term outcomes of the human immunodeficiency virus neuroretinal disorder in patients with AIDS. Ophthalmology. 2015;122:760–768.
   PubMed Web of Science ®Google Scholar
• Yust I, Fox Z, Burke M, et al. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994–2001. Eur J Clin Microbiol Infect Dis. 2004;23:550–559.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control (CDC). Pneumocystis pneumonia – Los Angeles. MMWR. 1981;30:250–252.
   PubMedGoogle Scholar
• Shi Y, Lu H, He T, et al. Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in Shanghai, China. BMC Infect Dis. 2011;11:326.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Ahuja A, Van Natta ML, et al. Long-term outcomes of cytomegalovirus retinitis in the era of modern antiretroviral therapy: results from a United States cohort. Ophthalmology. 2015;122:1452–1463.
   PubMed Web of Science ®Google Scholar
• Urban B, Bakunowicz-Lazarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Mediators Inflamm. 2014;2014:971417.
   PubMed Web of Science ®Google Scholar
• Holbrook JT, Colvin R, van Natta ML, et al. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. Am J Ophthalmol. 2011;152:628–637.
   PubMed Web of Science ®Google Scholar
• WHO. Global Tuberculosis Report 2014. Available at: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_engs.pdf?ua=1. Accessed 9 January, 2015.
   Google Scholar
• Mehta S. Ocular lesions in acute disseminated tuberculosis. Ocul Immunol Inflamm. 2004;12:311–315.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A, Sharma A. Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res. 2012;135:703–730.
   PubMed Web of Science ®Google Scholar
• Lorway R, Hwang SD, Reza-Paul S, et al. Sex in the city: privacy-making practices, spatialized intimacies and the environmental risks of men-who-have-sex-with-men in South India. Health Place. 2011;17:1090–1097.
   PubMed Web of Science ®Google Scholar
• Heiden D, Ford N, Wilson D, et al. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med. 2007;4:e334.
   PubMed Web of Science ®Google Scholar
• Pathanapitoon K, Ausayakhun S, Kunavisarut P, et al. Blindness and low vision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis. Retina. 2007;27:635–640.
   PubMed Web of Science ®Google Scholar
• Heiden D, Tun N, Maningding E, et al. Training clinicians treating HIV to diagnose cytomegalovirus retinitis. Bull World Health Organ. 2014;92:903–908.
   PubMed Web of Science ®Google Scholar
• Jirawison C, Yen M, Leenasirimakul P, et al. Telemedicine screening for cytomegalovirus retinitis at the point of care for human immunodeficiency virus infection. JAMA Ophthalmology. 2015;133:198–205.
   PubMed Web of Science ®Google Scholar
• Singh M, Das RR. Four years of experience of telemedicine for paediatric care in three Punjab hospitals, North India: achievements and lessons. Postgrad Med J. 2010;86:688–691.
   PubMed Web of Science ®Google Scholar
• Deghaide NH, Rodrigues Mde L, Castelli EC, et al. Tumor necrosis factor region polymorphisms are associated with AIDS and with cytomegalovirus retinitis. AIDS. 2009; 23:1641–1647.
   Google Scholar
• Arruda RF, Muccioli C, Belfort R, et al. [Ophthalmological findings in HIV infected patients in the post-HAART (Highly Active Anti-retroviral Therapy) era, compared to the pre-HAART era]. Rev Assoc Med Bras. 2004;50:148–152.
   PubMedGoogle Scholar